Your browser doesn't support javascript.
loading
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate.
Roozendaal, Ramon; Hendriks, Jenny; van Effelterre, Thierry; Spiessens, Bart; Dekking, Liesbeth; Solforosi, Laura; Czapska-Casey, Dominika; Bockstal, Viki; Stoop, Jeroen; Splinter, Daniel; Janssen, Sarah; Baelen, Ben van; Verbruggen, Nadia; Serroyen, Jan; Dekeyster, Eline; Volkmann, Ariane; Wollmann, Yvonne; Carrion, Ricardo; Giavedoni, Luis D; Robinson, Cynthia; Leyssen, Maarten; Douoguih, Macaya; Luhn, Kerstin; Pau, Maria Grazia; Sadoff, Jerry; Vandebosch, An; Schuitemaker, Hanneke; Zahn, Roland; Callendret, Benoit.
Affiliation
  • Roozendaal R; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands. RRoozend@its.jnj.com.
  • Hendriks J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • van Effelterre T; Janssen R&D, Beerse, Belgium.
  • Spiessens B; Janssen R&D, Beerse, Belgium.
  • Dekking L; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Solforosi L; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Czapska-Casey D; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Bockstal V; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Stoop J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Splinter D; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Janssen S; argenx BV, Gent, Belgium.
  • Baelen BV; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Verbruggen N; Janssen R&D, Beerse, Belgium.
  • Serroyen J; BVB Clin Consult BVBA, Mechelen, Belgium.
  • Dekeyster E; Janssen R&D, Beerse, Belgium.
  • Volkmann A; Galapagos NV, Mechelen, Belgium.
  • Wollmann Y; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Carrion R; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Giavedoni LD; Bavarian Nordic, Munich, Germany.
  • Robinson C; Bavarian Nordic, Munich, Germany.
  • Leyssen M; FGK Clinical Research, Munich, Germany.
  • Douoguih M; Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Luhn K; Texas Biomedical Research Institute, San Antonio, TX, USA.
  • Pau MG; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Sadoff J; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Vandebosch A; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Schuitemaker H; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Zahn R; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
  • Callendret B; Janssen Vaccines & Prevention B.V., Leiden, The Netherlands.
NPJ Vaccines ; 5(1): 112, 2020 Dec 17.
Article in En | MEDLINE | ID: mdl-33335092
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Vaccines Year: 2020 Type: Article Affiliation country: Netherlands
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Vaccines Year: 2020 Type: Article Affiliation country: Netherlands